InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-32.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Gordon Gary B.. Officer active across 3 companies, notably TriSalus Life Sciences, Inc.. Aggregated, 4 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €34k. Activity tracked since 16 May 2022. The latest transaction was filed on 14 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gordon Gary B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
28,201 股0Common StockSEC:0001628280-26-035665:0
9,756 股@ US$4.10100.0% 占其流量Common StockSEC:0001628280-26-010605:0
标准退出：2026年5月24日 (T+90)
58,520 股Common StockSEC:0001213900-23-004542:0
50,000 股0Common StockSEC:0000899243-22-018134:0
4 条申报中的 4 条
About Gordon Gary B.
Gordon Gary B. is a declarant linked to TriSalus Life Sciences, Inc., Old Ayala, Inc and Ayala Pharmaceuticals, Inc. He has 4 filings in total, and across the 4 recent filings held, the most frequent transaction nature is Attribution, with a date range from 2022-05-16 to 2026-05-15.
